Five things for pharma marketers to know: Monday, July 17, 2017
1. More Americans are reporting medication errors, according to an analysis of calls made to poison control centers in the U.S. Based on this data, about 400 people have died during a 13-year span due to medication errors. (WaPo)
2. Public Citizen is urging lawmakers to oppose a pair of proposals that would allow drugmakers to engage in some off-label marketing. (The Pharma Letter)
3. Bristol-Myers Squibb launched a new campaign called Ready. Raise. Rise, which seeks to raise awareness about immuno-oncology drugs. It features Eric Stonestreet, an actor from Modern Family, and Dak Prescott, a Dallas Cowboys quarterback.
4. The latest Senate Health bill is more likely to negatively impact people with pre-existing conditions such as cancer, asthma, and diabetes than an earlier version of the proposed legislation. (Kaiser Health News)
5. Novartis is making a play to market cheaper versions of the world's top arthritis drugs. Last month it received approval to market a biosimilar version of Amgen's Enbrel in the European Union. It also planning to submit applications for Johnson & Johnson's Remicade and AbbVie's Humira this year. (Reuters)